Connect with us

International

Best Health Care Stocks To Buy In Q4? 4 For Your Watchlist

Even the health care space seems to be on fire in terms of earnings this week.
The post Best Health Care Stocks To Buy In Q4? 4 For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

4 Health Care Stocks To Check Out In The Stock Market Today

Even with the focus on earnings season in the stock market this week, Covid continues to dominate the headlines. Because of this, health care stocks remain relevant regardless. After all, the health care industry is essentially the frontline of defense against the current pandemic. As countries across the globe ramp up their anti-pandemic measures, vaccine stocks, in particular, would gain traction. In fact, the White House announced plans to inoculate 5 to 11-year-olds once U.S. regulators approve vaccines for the group. Also, while upcoming names like Novavax (NASDAQ: NVAX) are reportedly facing hurdles in their approval processes, investors continue to watch anxiously.

At the same time, some industry titans in the health care space are also posting their earnings. Earlier today, leading biotech firm Biogen (NASDAQ: BIIB), posted solid figures in its latest quarterly earnings call. Notably, the company saw an earnings per share of $4.77 for the quarter, smashing consensus estimates of $4.11. Moreover, Biogen also beat projections on the top and bottom lines and is raising its full-year revenue outlook. Overall, the health care industry continues to power forward, regardless of the current situation with Covid. Should all this have you interested in the top health care stocks to watch, here are four in focus in the stock market now.

Top Health Care Stocks To Buy [Or Sell] This Week

Pfizer Inc.

First on this list, we have Pfizer, a multinational pharmaceutical and biotechnology company with headquarters in New York City. The company has been at the forefront of the fight against the pandemic. With its vaccine that was co-developed with BioNTech (NASDAQ: BNTX), it is well on track to deliver over 2 billion doses of its life-saving vaccines by the end of this year. Shares of PFE stock are trading at $42.99 a piece as of 11:48 a.m. ET. Today, the White House outlined a plan to distribute doses of the company’s vaccines to kids aged between 5 to 11 as soon as it is authorized by U.S. drug regulators.

Accordingly, the Biden administration said it has procured enough vaccines to inoculate all 28 million 5- to 11-year-olds in the U.S. A key U.S. Food and Drug Administration (FDA) vaccine advisory group is scheduled to meet next week to discuss Pfizer’s data. This is then followed by a Centers for Disease Control and Prevention (CDC) meeting on November 2. The shots could be approved shortly after these meetings, depending on how quickly the FDA and CDC respond. A report by CNN has also indicated that booster shots could soon be recommended for people as young as 40 with Moderna (NASDAQ: MRNA) and Pfizer’s Covid-19 vaccine. All things considered, should investors be adding PFE stock to their portfolios?

health care stocks (PFE stock chart)
Source: TD Ameritrade TOS

[Read More] Top Reddit Stocks To Buy Right Now? 5 For Your Late 2021 Watchlist

Abbott Laboratories

Another name to consider among health care stocks now would be Abbott Laboratories. In brief, Abbott is an Illinois-based medical device manufacturer. For a sense of scale, the company currently operates in over 160 countries across the globe. Through its vast array of medical tech, Abbott helps treat millions of patients around the world annually. In terms of end markets, the company’s offerings encompass the cardiovascular, Covid-testing, diabetes, nutrition, and neuromodulation industries. More importantly, ABT stock is now making waves in the stock market thanks to the company’s latest quarterly earnings report.

As it stands, the company’s shares now trade at $123.22 as of 11:49 a.m. ET after gaining by over 3% since today’s opening bell. Diving right in, Abbott reported an earnings per share of $1.40 on revenue of $10.93 billion. Comparatively, this is well over Wall Street’s estimates of $0.98 and $9.56 billion respectively. According to the company, its global diagnostics division saw a record growth of 48.2% year-over-year. This is, of course, attributed to the $1.9 billion in sales for its Covid-19 testing-related wares. With that in mind, would you be watching ABT stock?

top health care stocks (ABT stock)
Source: TD Ameritrade TOS

[Read More] Top Stocks To Buy Now? 4 Consumer Stocks To Consider

LumiraDx

LumiraDx is a next-generation point of care diagnostics company. It focuses on transforming community-based health care by providing critical diagnostic information to health care providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes while lowering costs. LMDX stock currently trades at $9.32 a piece as of 11:49 a.m. ET and is up by over 10% on today’s opening bell. Investors seem to be responding positively to news from the company today.

Diving in, the company announced that it had received emergency use approval by India’s Central Drugs Standard Control Organization for its Covid-19 antigen test for use in India. The test detects antigen nucleocapsid protein from a nasal swab and provides a result in under 12 minutes from sample application.

Impressively, its clinical studies have shown a 97.6% positive agreement and a 96.6% negative agreement with the PCR test for patients within the first twelve days of symptom. This would make LumiraDx’s test one of the fastest and most sensitive antigen point of care tests that are currently available in the market. The test kits are also available in the U.S. and Europe after receiving their respective regulatory approvals last year. Given this exciting piece of news, should you consider LMDX stock a buy right now?

LMDX stock chart
Source: TD Ameritrade TOS

[Read More] Best EV Stocks To Buy Right Now? 4 In Focus

Johnson & Johnson

Lastly, we have Johnson & Johnson. The company has been around for more than a century and is one of the largest and most broadly-based health companies in the world. Boasting over 130,000 employees worldwide, the company strives to improve access and affordability for the masses and continues to innovate tirelessly. JNJ stock trades at $164.52 as of 11:50 a.m. ET. On Tuesday, the company reported its third-quarter financials, beating analyst estimates.

Firstly, it reported that total sales grew by 10.7% to $23.3 billion. The company also reported a net earnings of $3.66 billion, or an earnings per share of $1.37. The company says that it saw solid performance across its business segments, driven by above-market results in Pharmaceuticals and ongoing recovery in Medical Devices. Furthermore, it also enjoyed strong growth in its Consumer Health segment. For this reason, will you add JNJ stock to your list of health care stocks?

JNJ stock chart
Source: TD Ameritrade TOS

The post Best Health Care Stocks To Buy In Q4? 4 For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

International

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

International

This is the biggest money mistake you’re making during travel

A retail expert talks of some common money mistakes travelers make on their trips.

Published

on

Travel is expensive. Despite the explosion of travel demand in the two years since the world opened up from the pandemic, survey after survey shows that financial reasons are the biggest factor keeping some from taking their desired trips.

Airfare, accommodation as well as food and entertainment during the trip have all outpaced inflation over the last four years.

Related: This is why we're still spending an insane amount of money on travel

But while there are multiple tricks and “travel hacks” for finding cheaper plane tickets and accommodation, the biggest financial mistake that leads to blown travel budgets is much smaller and more insidious.

A traveler watches a plane takeoff at an airport gate.

Jeshoots on Unsplash

This is what you should (and shouldn’t) spend your money on while abroad

“When it comes to traveling, it's hard to resist buying items so you can have a piece of that memory at home,” Kristen Gall, a retail expert who heads the financial planning section at points-back platform Rakuten, told Travel + Leisure in an interview. “However, it's important to remember that you don't need every souvenir that catches your eye.”

More Travel:

According to Gall, souvenirs not only have a tendency to add up in price but also weight which can in turn require one to pay for extra weight or even another suitcase at the airport — over the last two months, airlines like Delta  (DAL) , American Airlines  (AAL)  and JetBlue Airways  (JBLU)  have all followed each other in increasing baggage prices to in some cases as much as $60 for a first bag and $100 for a second one.

While such extras may not seem like a lot compared to the thousands one might have spent on the hotel and ticket, they all have what is sometimes known as a “coffee” or “takeout effect” in which small expenses can lead one to overspend by a large amount.

‘Save up for one special thing rather than a bunch of trinkets…’

“When traveling abroad, I recommend only purchasing items that you can't get back at home, or that are small enough to not impact your luggage weight,” Gall said. “If you’re set on bringing home a souvenir, save up for one special thing, rather than wasting your money on a bunch of trinkets you may not think twice about once you return home.”

Along with the immediate costs, there is also the risk of purchasing things that go to waste when returning home from an international vacation. Alcohol is subject to airlines’ liquid rules while certain types of foods, particularly meat and other animal products, can be confiscated by customs. 

While one incident of losing an expensive bottle of liquor or cheese brought back from a country like France will often make travelers forever careful, those who travel internationally less frequently will often be unaware of specific rules and be forced to part with something they spent money on at the airport.

“It's important to keep in mind that you're going to have to travel back with everything you purchased,” Gall continued. “[…] Be careful when buying food or wine, as it may not make it through customs. Foods like chocolate are typically fine, but items like meat and produce are likely prohibited to come back into the country.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

Trending